Coronary Artery Bypass Grafting Clinical Trial
Official title:
Multidisciplinary Collaborative Carotid Endarterectomy and Coronary Artery Bypass Graft Surgery to Optimize the Management of High-risk Patients During the Perioperative Period
Verified date | December 2019 |
Source | Peking University Third Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This project uses concurrent CEA+CABG combined surgery on high-risk patients with severe carotid artery stenosis and severe coronary artery stenosis. After multidisciplinary preoperative evaluation, intraoperative electrophysiological monitoring, and postoperative management standards, compare CEA+CABG combined operations during the same period And the advantages and disadvantages of a single CABG or CEA operation, the purpose is to explore the best surgical treatment plan, establish an interdisciplinary clinical medicine platform centered on patients with heart and cerebrovascular diseases, and develop a standard procedure and The perioperative management is standard, so it is particularly important and naturally has its advanced significance.
Status | Completed |
Enrollment | 30 |
Est. completion date | December 30, 2020 |
Est. primary completion date | July 30, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - (1) In patients with symptomatic carotid artery stenosis, the preoperative CTA or DSA, combined with carotid ultrasound and high-resolution magnetic resonance clearly diagnosed the degree of carotid artery stenosis on the responsible side>50%; (2) Patients with asymptomatic carotid artery stenosis before operation CTA or DSA, combined with carotid ultrasound and high-resolution magnetic resonance, clearly diagnosed the carotid artery stenosis rate of the affected side>70%; (3) All patients with carotid artery stenosis were located in the surgically accessible position, without complete carotid artery occlusion or intracranial segment Severe vascular stenosis; (4) The stenosis rate of the left main coronary artery by coronary angiography is more than 70%, or the disease of the three main vessels is more than 50%, and the bridging condition is good. Exclusion Criteria:(1) The disease is beyond the reach of surgery (such as C2 level or above); (2) The symptoms of hypertension are not effectively controlled before surgery (systolic blood pressure> 180mmHg); (3) Carotid artery stenosis caused by non-atherosclerosis , Such as arteritis, arterial dissection, vascular congenital malformations, etc.; (4) combined with hemorrhagic cerebrovascular diseases such as intracranial aneurysms or vascular malformations; (5) combined with blood system diseases that lead to coagulation dysfunction that cannot be corrected or refused to accept blood and blood Importers of products; (6) Pregnancy or perinatal period. - |
Country | Name | City | State |
---|---|---|---|
China | Peking University Third Hospital | Beijing |
Lead Sponsor | Collaborator |
---|---|
Peking University Third Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cerebral oxygen saturation | Cerebral oxygen saturation monitoring | Intraoperative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT01850082 -
Randomized Endo-Vein Graft Prospective
|
N/A | |
Not yet recruiting |
NCT04657835 -
Assessment of Atrial Cardiomyopathy Using MRI as a Predictor of Cardiac Post-Operative Atrial Fibrillation After Cardiac Surgery.
|
N/A | |
Completed |
NCT02889562 -
Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
|
Phase 2/Phase 3 | |
Completed |
NCT01378221 -
VItamin D Metabolism in SEnescent Cardiac Surgery Patients
|
N/A | |
Completed |
NCT01528514 -
Effects of CUrcuminoids on Coronary Artery byPass graftIng-related myocarDial Infarction Study
|
N/A | |
Completed |
NCT00848796 -
Comparative Study of Two Brands of Heparin Already on the Market
|
N/A | |
Not yet recruiting |
NCT05552586 -
Melatonin Impact on the Outcomes of Myocardial Ischemia/Reperfusion Injury During Coronary Artery Bypass Grafting Surgery
|
N/A | |
Completed |
NCT00246740 -
Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting
|
Phase 2 | |
Completed |
NCT00420667 -
Low Molecular Weight Heparin vs Unfractionated Heparin at Cardiac Surgery
|
N/A | |
Recruiting |
NCT04197700 -
The PRESSURE CABG Cardiac Surgery Trial
|
N/A | |
Not yet recruiting |
NCT05835167 -
Complete Revascularization Via Inferior Part-sternotomy
|
N/A | |
Not yet recruiting |
NCT06326996 -
Thiamine Intervention and Coronary Artery Bypass Grafting
|
N/A | |
Not yet recruiting |
NCT02732574 -
Oscillating Positive Expiratory Pressure (OPEP) Therapy in High Risk Patients Following Cardiac Surgery
|
N/A | |
Completed |
NCT00903604 -
Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery
|
Phase 2 | |
Completed |
NCT01182688 -
Prospective Review of Procalcitonin After Cardiac Surgery
|
N/A | |
Completed |
NCT02737215 -
Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting in Patients With Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT03209414 -
Frailty Syndrome in Daily Practice of Interventional Cardiology Ward
|
||
Recruiting |
NCT05441358 -
Assessment of Platelet Function in Patients Undergoing Open Heart Surgery
|
||
Recruiting |
NCT02400125 -
China Cardiovascular Surgery Registry
|
N/A |